Recruiting COPD Studies in Kansas City
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation...
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
Researchers are looking for ways to treat pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD). The goal of the study is to learn if people who take frespaciguat can walk...
About COPD Clinical Trials in Kansas City
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes breathing difficult, primarily caused by smoking. It includes emphysema and chronic bronchitis. Treatment involves bronchodilators, inhaled steroids, pulmonary rehabilitation, and oxygen therapy.
There are currently 2 copd clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 280 participants. Research is being sponsored by Connect Biopharm LLC, Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
COPD Clinical Trials in Kansas City — FAQ
Are there copd clinical trials in Kansas City?
Yes, there are 2 copd clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kansas City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.
Are clinical trials in Kansas City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.
What copd treatments are being tested?
The 2 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for copd.
Data updated March 2, 2026 from ClinicalTrials.gov